View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - GMMG-HD 6 - Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Elotuzumab 10, Multiple Myeloma, Induction, Cycle 1-2
Protocol-ID: 798 V1.1 (Mini), STUDY-GMMG-HD6 - BORT1,3/LENA25/DEXA20/ELOT10, MM, Ind. B1 + B2, C1-2Study protocol, available to authorized participants only.
Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 10.03.2020